| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Edesa Biotech, Inc. (EDSA) has 9 insiders with recent SEC Form 4 filings, including 9 buys and 4 sells. EDSA is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 501.8K | $2.79M | - | |
| Pres | 226.9K | $1.26M | - | |
| CFO | 65.0K | $360.8K | - | |
| Dir | 52.7K | $292.3K | - | |
| Dir | 30.4K | $168.8K | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Feb 26, 2026 | Brooks Michael J | President | Buy | 2,000 | $1.57 | $3,140.00 | +0.9% | |
| Mar 25, 2024 | Nijhawan Pardeep | Chief Executive Officer | Buy | 5,000 | $4.00 | $20,000.00 | +1.5% | |
| Jan 10, 2023 | Van Der Velden Peter | 10% Owner | Sell | 297,474 | $2.65 | $787,716.05 | -7.4% | |
| Jun 30, 2022 | Nijhawan Pardeep | Chief Executive Officer | Buy | 20,000 | $1.60 | $32,078.00 | +3.5% | |
| Jun 29, 2022 | Brooks Michael J | President | Buy | 3,000 | $1.49 | $4,482.90 | +12.9% | |
| Jun 16, 2022 | Brooks Michael J | President | Buy | 3,000 | $1.61 | $4,816.50 | +14.8% | |
| May 27, 2022 | Nijhawan Pardeep | Chief Executive Officer | Buy | 5,000 | $1.92 | $9,599.00 | +0.9% | |
| May 25, 2022 | Brooks Michael J | President | Buy | 3,500 | $1.74 | $6,090.00 | +20.9% | |
| May 24, 2022 | Nijhawan Pardeep | Chief Executive Officer | Buy | 2,000 | $1.80 | $3,599.60 | +0.4% | |
| Mar 31, 2022 | Nijhawan Pardeep | Chief Executive Officer | Buy | 2,000 | $2.99 | $5,971.60 | +0.4% |